Project Grant HT94252310179
Award Date 6/1/23
Completion Date 5/31/27
Dollars Obligated $3.8M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pullman, WA 99164, USA
Similar Awards
- The Washington State University will receive $1,377,000 from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on the novel role and therapeutic targeting of LMO4 in lethal prostate cancer from July 1, 2023 to June 30, 2026. Through this three-year Project Grant, WSU researchers will investigate medical solutions for the battlefield by exploring the oncogenic functions of LMO4 and developing targeted therapies to...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $765,000 Project Grant to Washington State University to support a 3-year research project titled "Identifying Novel Approaches for Melanoma Prevention Using Mouse Models with Humanized Telomeres". The research aims to develop new prevention strategies for melanoma by investigating the use of mouse models with humanized telomeres. The grant was awarded on September 30, 2023...
- The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $759,974 to Washington State University to develop a novel technique for introducing mutations in the native VlsE gene of Borrelia burgdorferi. The objective is to test several mechanistic concepts of VlsE-mediated immune evasion. This 3-year research project, starting on May 1, 2024 and ending on April 30, 2027, aims to advance the...
- Federal Grant Award Summary Wayne State University received a $400,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2025 through June 30, 2027. The award supports research titled "Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries," to be conducted at the university's Detroit, Michigan facility. This research initiative focuses on investigating...
- Federal Grant Award Summary Michigan State University received a $221,043 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), awarded July 1, 2025, with performance extending through June 30, 2027. The award supports light therapy research for tuberous sclerosis complex (TSC), a genetic disorder affecting multiple organ systems. This research initiative aligns with the Defense Health Agency's portfolio of hypothesis-driven...
- Federal Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $405,600 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2027. The award supports research on retinal repair via viral-mediated endogenous reprogramming of Müller glia cells, conducted at the University of Michigan's Ann Arbor campus. This research initiative...
- The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $447,625 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, through May 31, 2028. This award supports research on refractive surgery for autism spectrum disorder (ASD), leveraging the university's established capabilities in advanced biomedical research and clinical investigation. The...
- This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...